当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析

国药一致

(000028)

  

流通市值:123.34亿  总市值:143.59亿
流通股本:4.78亿   总股本:5.57亿

国药一致(000028)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润7.13亿元,每股收益1.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益2125042.19万元,未分配利润1303775.48万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产5042613.58万元,负债2917571.39万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入36,796,598,397.4218,293,519,382.4974,378,494,389.5756,466,354,478.37
营业总成本35,955,918,659.0117,881,473,183.9873,017,475,226.7755,384,596,098.97
其他经营收益
营业利润926,496,477.17439,138,215.7573,478,281.111,344,444,922.23
利润总额918,113,302.33438,326,864.61575,469,437.321,356,463,270.05
净利润712,593,802.45347,677,306.8237,003,526.491,095,669,310.29
每股收益
其他综合收益-36,254.21--15,541,136.14-13,914.59
综合收益总额712,557,548.24347,677,306.8221,462,390.351,095,655,395.7
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计40,862,745,995.8140,139,860,703.337,576,395,698.7740,678,316,958.96
非流动资产:
非流动资产合计9,563,389,791.159,883,181,465.799,979,464,716.4511,302,538,613.35
资产总计50,426,135,786.9650,023,042,169.0947,555,860,415.2251,980,855,572.31
流动负债:
流动负债合计27,463,387,041.3727,037,737,859.0724,802,407,197.7928,092,983,684.06
非流动负债:
非流动负债合计1,712,326,820.551,883,361,206.631,998,053,899.612,233,506,658.27
负债合计29,175,713,861.9228,921,099,065.726,800,461,097.430,326,490,342.33
所有者权益(或股东权益):
归属于母公司股东权益合计18,136,171,801.717,997,526,867.7817,669,528,375.6518,101,879,082.99
股东权益合计21,250,421,925.0421,101,943,103.3920,755,399,317.8221,654,365,229.98
负债和股东权益合计50,426,135,786.9650,023,042,169.0947,555,860,415.2251,980,855,572.31
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计36,741,745,189.2816,224,803,696.9380,408,700,561.6156,625,996,162.02
经营活动现金流出小计36,726,678,49918,042,073,694.7777,137,232,264.5855,344,904,053.93
经营活动产生的现金流量净额15,066,690.28-1,817,269,997.843,271,468,297.031,281,092,108.09
投资活动产生的现金流量:
投资活动现金流入小计50,731,325.014,362,484.59217,442,245.19216,988,662.26
投资活动现金流出小计114,799,722.0764,305,655.73368,127,854.62288,221,019.36
投资活动产生的现金流量净额-64,068,397.06-59,943,171.14-150,685,609.43-71,232,357.1
筹资活动产生的现金流量:
筹资活动现金流入小计1,077,469,213.33661,184,385.131,824,239,928.711,410,753,157.68
筹资活动现金流出小计1,740,308,910.55569,123,338.513,655,476,076.733,396,976,558.98
筹资活动产生的现金流量净额-662,839,697.2292,061,046.62-1,831,236,148.02-1,986,223,401.3
汇率变动对现金及现金等价物的影响-74,564.57873.42-1,196,465.06-1,200,190.66
现金及现金等价物净增加额-711,915,968.57-1,785,151,248.941,288,350,074.52-777,563,840.97
期末现金及现金等价物余额6,411,728,562.35,338,493,281.937,123,644,530.875,057,730,615.38
补充资料:
现金及现金等价物的净增加额-711,915,968.57-1,288,350,074.52-
最新报告期:2025-09-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,孔垂岩,王殷杰2.432.482.522025-09-01
中金公司张琎,朱言音1.621.80--2025-08-15
TOP↑